Canada markets closed

Reckitt Benckiser Group plc (RBGLY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
17.66-0.02 (-0.11%)
At close: 03:56PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close17.68
Bid0.00 x 0
Ask0.00 x 0
Day's Range17.61 - 17.77
52 Week Range14.82 - 19.30
Avg. Volume1,012,808
Market Cap63.083B
Beta (5Y Monthly)0.14
PE Ratio (TTM)N/A
EPS (TTM)-0.62
Earnings DateN/A
Forward Dividend & Yield0.49 (2.76%)
Ex-Dividend DateAug. 05, 2021
1y Target EstN/A
  • Reuters

    Reckitt takes steps to calm pricing row in India

    British consumer giant Reckitt Benckiser sought to allay the concerns of its army of sales agents in India about unfair pricing, saying it had taken steps to ensure a level playing field for distributors, a letter seen by Reuters showed. The assurance followed a Reuters story in November that revealed sales agents of companies including Reckitt, Unilever and Colgate were angry that mom-and-pop stores - known as kiranas in India - increasingly ordered from Indian retailer Reliance's mobile app because they could get lower prices.

  • Reuters

    UPDATE 1-Reckitt to sell E45 skincare brand to Karo Pharma for $268 mln

    Reckitt Benckiser said on Friday it plans to sell its E45 skincare brand and related sub-brands to Karo Pharma for 200 million pounds ($267.98 million), as the British consumer goods maker shifts focus to higher growth areas. The Slough-based company has been trimming its portfolio to concentrate on high growth categories such as disinfectants and health care products that have seen a boom during the COVID-19 pandemic. In February, Reckitt sold its Scholl footcare business to private equity firm Yellow Wood Partners, and a few months later signed a deal to sell its infant formula business in China for $2.2 billion to Primavera Capital Group.

  • PA Media: Money

    Reckitt to sell E45 skincare brand for £200m

    E45 cream was created in 1952 by Reckitt subsidiary Crookes Healthcare.